Innovations

GH Labs' early-stage research and analysis show liquid oxygen cryo cannisters hold promise for reducing costs in the distribution and point-of-care use of medical oxygen.

GH Labs is developing a low-cost, non-invasive diagnostic approach to more easily detect and ultimately treat patients with TB.